Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Safety Concerns Halt Depression Trials; Gen Z and Alcohol; Prescribing Benzos

(MedPage Today) -- Xenon Pharmaceuticals said it paused enrollment in its major depressive disorder and bipolar depression trials after unexpected neuropsychiatric adverse events emerged. Many mental health and suicide risk indicators among youth...

Safety Concerns Halt Depression Trials; Gen Z and Alcohol; Prescribing Benzos

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Wednesday 23 September →